Finasteride is a potent, competitive Type II 5-alpha reductase enzyme inhibitor utilized to establish long-term endocrine balance in testosterone-dependent tissues. It functions by specifically binding to the Type II intracellular enzyme, completely blocking the metabolic conversion of linear testosterone into the highly potent androgen dihydrotestosterone (DHT). Because DHT is the primary hormone driving prostate gland enlargement and hair follicle miniaturization, lowering circulating and tissue DHT levels causes a steady, step-by-step physical shrinkage of hyperplastic prostate tissue, increases urinary flow clearance, reverses structural hair thinning, and keeps the prostate environment systemically stabilized.